Descriptor English: | Pramipexole | ||||||
Descriptor Spanish: |
Pramipexol
| ||||||
Descriptor Portuguese: | Pramipexol | ||||||
Descriptor French: | Pramipexole | ||||||
Entry term(s): |
2 Amino 6 propylaminotetrahydrobenzothiazole 2-Amino-4,5,6,7-tetrahydro-6-propylaminobenzothiazole 2-Amino-6-propylaminotetrahydrobenzothiazole 4,5,6,7-Tetrahydro-N6-propyl-2,6-benzothiazole-diamine 6,7-Tetrahydro-N6-propyl-2,6-benzothiazolediamine dihydrochloride monohydrate Mirapex Pramipexol Pramipexol Dihydrobromide, (+-)-isomer Pramipexol Dihydrochloride, (S)-isomer Pramipexol, (+-)-isomer Pramipexole Dihydrochloride Pramipexole Dihydrochloride Anhydrous Pramipexole Hydrochloride Monohydrate SND 919 SND-919 Sifrol |
||||||
Tree number(s): |
D03.383.129.708.089.514 D03.633.100.185.514 |
||||||
RDF Unique Identifier: | https://id.nlm.nih.gov/mesh/D000077487 | ||||||
Scope note: | A benzothiazole derivative and dopamine agonist with antioxidant properties that is used in the treatment of PARKINSON DISEASE and RESTLESS LEGS SYNDROME. |
||||||
Allowable Qualifiers: |
AA analogs & derivatives AD administration & dosage AE adverse effects AG agonists AI antagonists & inhibitors AN analysis BL blood CF cerebrospinal fluid CH chemistry CL classification CS chemical synthesis EC economics HI history IM immunology IP isolation & purification ME metabolism PD pharmacology PK pharmacokinetics PO poisoning RE radiation effects SD supply & distribution ST standards TO toxicity TU therapeutic use UR urine |
||||||
Pharm Action: |
Antioxidants Antiparkinson Agents Dopamine Agonists |
||||||
Registry Number: | 83619PEU5T | ||||||
CAS Type 1 Name: | 2,6-Benzothiazolediamine, 4,5,6,7-tetrahydro-N6-propyl-, (S)- | ||||||
Public MeSH Note: | 2019; PRAMIPEXOLE was indexed under BENZOTHIAZOLES 2007-2018; and under THIAZOLES 1989-2006 |
||||||
History Note: | 2019 (1989) |
||||||
DeCS ID: | 57660 | ||||||
Unique ID: | D000077487 | ||||||
Documents indexed in the Virtual Health Library (VHL): | Click here to access the VHL documents | ||||||
Date Established: | 2019/01/01 | ||||||
Date of Entry: | 2018/07/09 | ||||||
Revision Date: | 2018/04/09 |
-
-
CHEMICALS AND DRUGS
Heterocyclic Compounds [D03]Heterocyclic Compounds -
CHEMICALS AND DRUGS
Heterocyclic Compounds [D03]Heterocyclic Compounds
|
Pramipexole
- Preferred
Mirapex
- Narrower
Pramipexol Dihydrobromide, (+-)-isomer
- Narrower
Pramipexol Dihydrochloride, (S)-isomer
- Narrower
Pramipexole Dihydrochloride Anhydrous
- Narrower
Sifrol
- Narrower
SND-919
- Narrower
Pramipexol, (+-)-isomer
- Narrower
Pramipexole Dihydrochloride
- Narrower
2-Amino-6-propylaminotetrahydrobenzothiazole
- Related but not broader or narrower
6,7-Tetrahydro-N6-propyl-2,6-benzothiazolediamine dihydrochloride monohydrate
- Narrower
Concept UI |
M0170120 |
Scope note | A benzothiazole derivative and dopamine agonist with antioxidant properties that is used in the treatment of PARKINSON DISEASE and RESTLESS LEGS SYNDROME. |
Preferred term | Pramipexole |
Entry term(s) |
2-Amino-4,5,6,7-tetrahydro-6-propylaminobenzothiazole 4,5,6,7-Tetrahydro-N6-propyl-2,6-benzothiazole-diamine Pramipexol |
Concept UI |
M0398863 |
Preferred term | Mirapex |
Concept UI |
M0324395 |
Preferred term | Pramipexol Dihydrobromide, (+-)-isomer |
Concept UI |
M0324392 |
Preferred term | Pramipexol Dihydrochloride, (S)-isomer |
Concept UI |
M000640809 |
Preferred term | Pramipexole Dihydrochloride Anhydrous |
Concept UI |
M0559410 |
Preferred term | Sifrol |
Concept UI |
M0170118 |
Preferred term | SND-919 |
Entry term(s) |
SND 919 |
Concept UI |
M0324394 |
Preferred term | Pramipexol, (+-)-isomer |
Concept UI |
M000640808 |
Preferred term | Pramipexole Dihydrochloride |
Entry term(s) |
Pramipexole Hydrochloride Monohydrate |
Concept UI |
M000640807 |
Preferred term | 2-Amino-6-propylaminotetrahydrobenzothiazole |
Entry term(s) |
2 Amino 6 propylaminotetrahydrobenzothiazole |
Concept UI |
M000607800 |
Preferred term | 6,7-Tetrahydro-N6-propyl-2,6-benzothiazolediamine dihydrochloride monohydrate |
We want your feedback on the new DeCS / MeSH website
We invite you to complete a survey that will take no more than 3 minutes.
Go to survey